Locally Advanced Cancer of the Esophagus, Current Treatment Strategies, and Future Directions

by Rahma, Osama E., Greten, Tim F., Duffy, Austin
Published 2012

Human Th17 cells in patients with cancer: Friends or foe?

by Greten, Tim F., Zhao, Fei, Gamrekelashvili, Jaba, Korangy, Firouzeh
Published 2012

Tumour-Associated Transcripts and EGFR Deletion Variants in Colorectal Cancer in Primary Tumour, Metastases and Circulating Tumour Cells

by Lankiewicz, Silke, Rother, Eva, Zimmermann, Silke, Hollmann, Christiane, Korangy, Firouzeh, Greten, Tim F.
Published 2008

Tumor Induced Hepatic Myeloid Derived Suppressor Cells Can Cause Moderate Liver Damage

by Eggert, Tobias, Medina-Echeverz, José, Kapanadze, Tamar, Kruhlak, Michael J., Korangy, Firouzeh, Greten, Tim F.
Published 2014

Agonistic CD40 antibody induces immune-mediated liver damage and modulates tumor-induced myeloid suppressive cells

by Medina-Echeverz, Jose, Ma, Chi, Duffy, Austin, Kleiner, David E, Greten, Tim F
Published 2014

Immune studies in a mouse model of MET and CAT induced liver tumors

by Eggert, Tobias, Medina-Echeverz, Jose, Ma, Chi, Stauffer, Jimmy K, Wiltrout, Robert H, Greten, Tim F
Published 2014

Primary sterile necrotic cells fail to cross-prime CD8+ T cells

by Gamrekelashvili, Jaba, Ormandy, Lars A., Heimesaat, Markus M., Kirschning, Carsten J., Manns, Michael P., Korangy, Firouzeh, Greten, Tim F.
Published 2012

Hepatic myeloid-derived suppressor cells in tumor bearing mice exacerbate hepatitis and transform into pro-inflammatory myeloid cells

by Medina-Echeverz, Jose, Kapanadze, Tamar, Ma, Chi, Duffy, Austin, Gamrekelashvili, Jaba, Kapoor, Veena, Weiss, Jonathan M, Wiltrout, Robert H, Berzofsky, Jay, Terabe, Masaki, Manns, Michael P, Marincola, Francesco M, Wang, Ena, Korangy, Firouzeh, Greten, Tim F
Published 2013

Paired tumor biopsy analysis and safety data from a pilot study evaluating Tremelimumab - a monoclonal antibody against CTLA-4 - in combination with ablative therapy in patients wi...

by Duffy, Austin, Kerkar, Sid P, Kleiner, David E, Ulahannan, Susanna, Kurtoglu, Metin, Rusher, Oxana, Fioravanti, Suzanne, Walker, Melissa, Figg, William D, Compton, Kathryn, Venkatesan, Aradhana, Abi-Jaoudeh, Nadine, Wood, Brad, Greten, Tim F
Published 2014

Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards

by Bronte, Vincenzo, Brandau, Sven, Chen, Shu-Hsia, Colombo, Mario P., Frey, Alan B., Greten, Tim F., Mandruzzato, Susanna, Murray, Peter J., Ochoa, Augusto, Ostrand-Rosenberg, Suzanne, Rodriguez, Paulo C., Sica, Antonio, Umansky, Viktor, Vonderheide, Robert H., Gabrilovich, Dmitry I.
Published 2016

NAFLD causes selective CD4+ T lymphocyte loss and promotes hepatocarcinogenesis

by Ma, Chi, Kesarwala, Aparna H., Eggert, Tobias, Medina-Echeverz, José, Kleiner, David E., Jin, Ping, Stroncek, David F., Terabe, Masaki, Kapoor, Veena, ElGindi, Mei, Han, Miaojun, Thornton, Angela M., Zhang, Haibo, Egger, Michèle, Luo, Ji, Felsher, Dean W., McVicar, Daniel W., Weber, Achim, Heikenwalder, Mathias, Greten, Tim F.
Published 2016

pERK, pAKT and p53 as tissue biomarkers in erlotinib-treated patients with advanced pancreatic cancer: a translational subgroup analysis from AIO-PK0104

by Ormanns, Steffen, Siveke, Jens T, Heinemann, Volker, Haas, Michael, Sipos, Bence, Schlitter, Anna Melissa, Esposito, Irene, Jung, Andreas, Laubender, Rüdiger P, Kruger, Stephan, Vehling-Kaiser, Ursula, Winkelmann, Cornelia, Fischer von Weikersthal, Ludwig, Clemens, Michael R, Gauler, Thomas C, Märten, Angela, Geissler, Michael, Greten, Tim F, Kirchner, Thomas, Boeck, Stefan
Published 2014